Javascript must be enabled to continue!
Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome
View through CrossRef
Abstract
ObjectiveTo compare serum Nesfatin 1 levels in Indian women with and without PCOS and to evaluate the association of serum Nesfatin 1 with metabolic and clinical parameters.Methods and Material40 PCOS and 40 age and BMI matched non PCOS controls were enrolled. Comparison of hormonal (serum Nesfatin 1, AMH, FSH, LH, prolactin, testosterone, estadiol) metabolic (blood pressure, fasting and post prandial blood glucose and insulin, HOMA-IR ) and clinical (acne, acanthosis nigricans and hirsutism) parameters was done between two groups. Student’s t test, Mann Whitney test, Pearson’s correlation test were used. P value of < 0.05 was considered statistically significant.ResultsThere was a significant difference in levels of serum Nesfatin 1 in PCOS subjects and controls (8.6 ng/ml v.s 0.75 ng/ml, p < 0.01). Positive correlation was present between serum nesfatin 1 levels and post prandial plasma glucose (r = 0.009; p < 0.009). A positive correlation was also present between serum Nesfatin 1 levels and AMH (r = 0.512;p < 0.01). No correlation was found between serum Nesfatin 1 and other endocrine, cardiovascular and metabolic parameters. Serum LH levels, LH/FSH ratio, post prandial plasma glucose and post prandial insulin were significantly higher (P < 0.05). in PCOS subjects compared to controlsConclusionNesfatin1 levels were ten times higher in PCOS subjects compared to controls irrespective of age and BMI. A positive correlation was observed between serum Nesfatin 1 and post prandial plasma glucose levels which indicates Nesfatin 1 may be a reliable marker of PCOS suggesting energy homeostasis imbalance in these women.
Title: Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome
Description:
Abstract
ObjectiveTo compare serum Nesfatin 1 levels in Indian women with and without PCOS and to evaluate the association of serum Nesfatin 1 with metabolic and clinical parameters.
Methods and Material40 PCOS and 40 age and BMI matched non PCOS controls were enrolled.
Comparison of hormonal (serum Nesfatin 1, AMH, FSH, LH, prolactin, testosterone, estadiol) metabolic (blood pressure, fasting and post prandial blood glucose and insulin, HOMA-IR ) and clinical (acne, acanthosis nigricans and hirsutism) parameters was done between two groups.
Student’s t test, Mann Whitney test, Pearson’s correlation test were used.
P value of < 0.
05 was considered statistically significant.
ResultsThere was a significant difference in levels of serum Nesfatin 1 in PCOS subjects and controls (8.
6 ng/ml v.
s 0.
75 ng/ml, p < 0.
01).
Positive correlation was present between serum nesfatin 1 levels and post prandial plasma glucose (r = 0.
009; p < 0.
009).
A positive correlation was also present between serum Nesfatin 1 levels and AMH (r = 0.
512;p < 0.
01).
No correlation was found between serum Nesfatin 1 and other endocrine, cardiovascular and metabolic parameters.
Serum LH levels, LH/FSH ratio, post prandial plasma glucose and post prandial insulin were significantly higher (P < 0.
05).
in PCOS subjects compared to controlsConclusionNesfatin1 levels were ten times higher in PCOS subjects compared to controls irrespective of age and BMI.
A positive correlation was observed between serum Nesfatin 1 and post prandial plasma glucose levels which indicates Nesfatin 1 may be a reliable marker of PCOS suggesting energy homeostasis imbalance in these women.
Related Results
Evidence of Nesfatin-1 in Mouse Intestinal Enteroendocrine Cells
Evidence of Nesfatin-1 in Mouse Intestinal Enteroendocrine Cells
Objectives: Post-prandial insulin secretion is predominantly regulated by four intestinal hormones: glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (G...
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
Abstract
Study question
Could ovarian vascularity indices, measured by 3-dimensional (3D) vaginal power Doppler, predict the num...
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract
Introduction: The paired-box (PAX) genes encode a family of transcription factors (TFs) with critical roles in the formation of tissues and organs during em...
Copeptin and Nesfatin-1 are interesting interrelated biomarkers playing a role in the pathogenesis of insulin resistance in Chinese obese children
Copeptin and Nesfatin-1 are interesting interrelated biomarkers playing a role in the pathogenesis of insulin resistance in Chinese obese children
Abstract
Background Recently, copeptin and nesfatin-1 have been identified as interesting novel peptides playing a role in the pathogenesis of obesity-related insulin resis...
Whole-Body Loss of NUCB2/Nesfatin-1 Alters Enteric Hormone Expression
Whole-Body Loss of NUCB2/Nesfatin-1 Alters Enteric Hormone Expression
Objectives: Post-prandial insulin secretion is predominantly regulated by four intestinal hormones: glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (G...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract
Epithelial ovarian cancer (EOC) accounts for 5% of all cancer deaths and is the fifth leading cause of cancer death in women in the United States. While the...
Abstract DP-007: POLYCYSTIC OVARY SYNDROME AND OVARIAN CANCER RISK: A MENDELIAN RANDOMIZATION ANALYSIS
Abstract DP-007: POLYCYSTIC OVARY SYNDROME AND OVARIAN CANCER RISK: A MENDELIAN RANDOMIZATION ANALYSIS
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS), a complex endocrine disorder that has an estimated prevalence of 4-21% in reproductive aged women, is characte...

